Prosecution Insights
Last updated: October 04, 2026
Application No. 18/514,724

CUTTING SUBASSEMBLY AND CONDITIONING ASSEMBLY FOR AN ENVIRONMENT

Final Rejection §102§103§112
Filed
Nov 20, 2023
Priority
Oct 04, 2022 — provisional 63/378,334 +1 more
Examiner
BOWERS, NATHAN ANDREW
Art Unit
1799
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Rapid Micro Biosystems Inc.
OA Round
2 (Final)
59%
Grant Probability
Moderate
3-4
OA Rounds
8m
Est. Remaining
91%
With Interview

Examiner Intelligence

Grants 59% of resolved cases
59%
Career Allowance Rate
816 granted / 1374 resolved
-5.6% vs TC avg
Strong +32% interview lift
Without
With
+31.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
63 currently pending
Career history
1429
Total Applications
across all art units

Statute-Specific Performance

§101
0.5%
-39.5% vs TC avg
§103
53.9%
+13.9% vs TC avg
§102
13.6%
-26.4% vs TC avg
§112
18.3%
-21.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1374 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. Claim 10 is rejected under 35 U.S.C. 112(b) as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor regards as the invention. Claim 10 recites a limitation relating to a “ring-shaped foil cutter” that is not an element of the “tray assembly” set forth in claim 1. The specification identifies that the ring-shaped foil cutter 160 (see Fig. 4) is a feature that is usable with, but distinct from, the tray assembly 700 (see Fig. 7). Therefore, it is unclear how the foil cutter of claim 10 is said to be a component of the tray assembly set forth in the preamble of independent claim 1. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1, 2, 6-9, 11, 12, 17 and 18 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Olivier (US 20180328823). With respect to claim 1, Olivier discloses a tray assembly for a cassette assembly comprising a tray (Figure 3B:3) configured to receive an oxygen-scavenging material (Figure 1C:23). A seal (Figure 1A:4) is configured to create an airtight seal on a bottom side (“first side”) of the tray, such that the seal may be used to block a communication path (Figure 3C:8). The tray is covered by a lid (Figure 6:26) that is positioned over an open top, which functions as a fill port to receive the oxygen-scavenging material 23. The fill port covered by the lid is disposed on a top side (“second side”) of the tray that is opposite the bottom side. This is described in paragraphs [0045]-[0049]. PNG media_image1.png 237 734 media_image1.png Greyscale With respect to claim 2, Olivier discloses the apparatus as described above. Olivier further states that a shelf is configured to be disposed within the tray. PNG media_image2.png 195 290 media_image2.png Greyscale With respect to claims 6, 7 and 9, Olivier discloses the apparatus as described above. Oliver shows that the tray is “C”-shaped, and that the open top may be filled at ports at each end of the “C” shape. As discussed above, the cover 26 provides an air-tight seal when disposed above the fill ports. [AltContent: arc] PNG media_image3.png 202 378 media_image3.png Greyscale With respect to claim 8, Olivier discloses the apparatus as described above. Olivier shows in Fig. 2 that the tray 3 substantially surrounds an internal testing environment 3 of the cassette assembly. With respect to claim 11, Olivier discloses the apparatus as described above. Olivier teaches a corresponding method in which the tray is filled with oxygen-scavenging material 23 through the one or more fill ports (Fig. 1C) and a seal is applied to the tray via movement of a tap device 4. With respect to claim 12, Olivier discloses the method as described above. Olivier further states that a shelf is deployed inside the tray (see rejection of claim 2). With respect to claims 17 and 18, Olivier discloses the method as described above. Oliver shows that tray may be subdivided 3a, 3b, and that each subunit includes an open top comprising a fill port. As discussed above, the cover 26 provides an air-tight seal when disposed above the fill ports. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 3 and 13 are rejected under 35 U.S.C. 103 as being unpatentable over Olivier (US 20180328823) as applied to claims 1 and 11, and further in view of Brewer (US 5034331). Olivier discloses the apparatus and method in claims 1 and 11, however does not teach that a foam insert used to prevent oxygen-scavenging material from exiting the tray. Brewer discloses a tray assembly configured to receive an oxygen-scavenging material. The oxygen-scavenging material is a metal hydrosulfite that is dispersed in a gel composition (Figure 1:20) configured as a foam. The foam gel composition 20 immobilizes the oxygen-scavenging material in the headspace above a cell culture medium (Figure 1:16). Before the effective filing date of the claimed invention, it would have been obvious to modify Olivier to include a foam insert configured to prevent oxygen-scavenging material from exiting the tray when the seal is broken. Brewer teaches that oxygen-scavenging materials are desirably dispersed in a gel/foam composition to position the oxygen-scavenging materials in communication with cell culture gases, but not directly in communication with the culture liquid. Those of ordinary skill would understand that this would remove oxygen from the culture headspace to promote anaerobic conditions while preventing direct contamination of the culture fluid with toxic materials. Claims 4, 5, 14-16, 19 and 20 are rejected under 35 U.S.C. 103 as being unpatentable over Olivier (US 20180328823) as applied to claims 1 and 11, and further in view of Beall (US 4347222). Olivier discloses the apparatus and method as described above, however does not teach that the seal is a foil that is punctured by a cutting subassembly. Beall discloses a tray assembly (Figure 1:10) configured to receive an oxygen-scavenging material (Figure 4:48) that is activated when a seal (Figure 4:47 and Figure 3:46) is ruptured by a cutter (Figure 3:55). This is described in column 3, line 10 to column 4, line 14. Beall states that the seal is formed within the tray assembly using heat sealing techniques. Heat welding and adhesives are considered to be functionally equivalent and interchangeable sealing mechanisms. Before the effective filing date of the claimed invention, it would have been obvious to provide the Olivier tray assembly with an alternative sealing/cutting means, such as a foil that is punctured by a cutter. Beall teaches that this is an effective way to expose oxygen-removing agent to an enclosed cassette environment at a desired time in a controllable manner. Beall teaches that a foil may be “conveniently formed” using simple techniques, and that the seal is readily broken by a user when desired by pushing the cutter into contact with the foil. Response to Arguments Applicant's arguments filed 05 August 2026 have been fully considered but they are not persuasive. Applicant argues that claim 10 is not indefinite because paragraph [0029] of the specification states that the try assembly may also include a ring-shaped foil cutter configured to penetrate the seal. However, the specification repeatedly refers to the cutter and the tray assembly as distinct and separate features, such that the cutter is not a component of the tray assembly. Paragraphs [0047]-[0050] and [0089]-[0096] describe the assembled tray assembly 700. Although the cutter 106 is said to interact with the foil seal 604 of the tray assembly 700, the cutter is described as an independent unit. The assembled tray assembly 700 is shown in Fig. 7 without the cutter depicted as a sub element. The assembled tray assembly 700 is shown in Figs. 8 and 9 without the cutter depicted as a sub element. The assembled tray assembly 700 is shown in Fig. 10 without the cutter depicted as a sub element. The cutter 106 is independently shown in Figs. 4-5d without reference to the tray assembly. Indeed, the cutter 106 and tray assembly 700 are organized as sub elements of the cassette assembly 100. See Fig. 1. It is consistent with the specification to state that The cassette assembly 100 comprises lid 102 [AltContent: rect]cutter 106 [AltContent: textbox (Subject matter of the instant claims)][AltContent: arrow]tray assembly 700 tray seal fill ports Etc. (mid body assembly, base assembly) It is inconsistent with the specification to state that The cassette assembly 100 comprises lid 102 tray assembly 700 cutter tray seal fill ports Etc. (mid body assembly, base assembly) Applicant argues that the Olivier fill port and seal are disposed on the same side of the tray, as opposed to oppositely arranged first and second sides. This does not appear to be correct because Olivier teaches that the seal (Figure 1A:4) is configured to create an airtight seal on a bottom side (“first side”) of the tray, such that the seal may be used to block a communication path (Figure 3C:8). The tray is covered by a lid (Figure 6:26) that is positioned over an open top, which functions as a fill port to receive the oxygen-scavenging material 23. The fill port covered by the lid is disposed on a top side (“second side”) of the tray that is opposite the bottom side. This is described in paragraphs [0045]-[0049]. PNG media_image1.png 237 734 media_image1.png Greyscale PNG media_image4.png 273 326 media_image4.png Greyscale Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to NATHAN ANDREW BOWERS whose telephone number is (571)272-8613. The examiner can normally be reached M-F 7am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Michael Marcheschi can be reached at (571) 272-1374. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /NATHAN A BOWERS/ Primary Examiner, Art Unit 1799
Read full office action

Prosecution Timeline

Nov 20, 2023
Application Filed
May 05, 2026
Non-Final Rejection mailed — §102, §103, §112
Aug 05, 2026
Response Filed
Aug 18, 2026
Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12747422
METHOD AND APPARATUS FOR PROCESSING TISSUE SAMPLES
2y 7m to grant Granted Sep 29, 2026
Patent 12735668
PRIMING METHOD AND BIOLOGICAL COMPONENT TREATMENT SYSTEM
4y 6m to grant Granted Sep 15, 2026
Patent 12729365
BIOMASS REACTOR AND PROCESS
3y 4m to grant Granted Sep 08, 2026
Patent 12723228
Differential Flow Micro-valve Sampling in Integrated Sensor Platform for Cell or Tissue Culture and Analysis
3y 10m to grant Granted Sep 01, 2026
Patent 12716045
Sampling Method
3y 2m to grant Granted Aug 25, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
59%
Grant Probability
91%
With Interview (+31.9%)
3y 6m (~8m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1374 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month